explore -WSS

explore

author：knowledge 2025-09-30 00:37:21 - browse：763

foreign-trained health professionals — Adobe

The pharmaceutical industry has been up in arms over Medicare’s first list of 10 prescription drugs that will be subject to negotiations. But other major parts of the health care industry — hospitals, doctors, and other providers — have refrained from either lending support or criticizing the government’s process.

The American Hospital Association, the industry’s main lobbying group, told STAT it is “not commenting on this issue right now.” The American Medical Association had no comment and deferred to other physician trade groups. The Federation of American Hospitals offered no statement.

The American Health Care Association, which lobbies on behalf of nursing homes, did not comment on the list of 10 drugs or Medicare’s negotiating power. But it said in a statement that “many nursing home residents have multiple chronic conditions that require several medications, so any efforts at reducing their out-of-pocket costs would be welcome.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： How to convince healthy people to buy insurance

hotspot

WSS

The health care issue Democrats can’t solve: hospital reform

The problem with charging patients to message their doctors

Humans aren't the only ones with an imagination. Rats have it too

Air quality improving but still lags in Black, Hispanic communities

The health care issue Democrats can’t solve: hospital reform

Readout LOUD podcast: ESMO highlights & Roivant's big deal

knowledge

explore

Wikipedia

Trump demands the U.S. pay no more for drugs than other countries … again

What it’s like to watch children die of measles

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Medical leaders decry Supreme Court decision on affirmative action

Travis Kelce and the trap of celebrity vaccine endorsements

After affirmative action ruling, medical educators look to 'holistic review'

NEJM study link tiny plastics in blood vessels to heart problems

What does generative AI mean for health care? We asked experts

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Wikipedia

Infant mortality in U.S. rose last year for first time in decades: CDC

Amylyx ALS drug failure raises questions and concerns

Readout LOUD podcast: ESMO highlights & Roivant's big deal

What it’s like to watch children die of measles

Inari Medical to buy amputation prevention company LimFlow

Change Healthcare cyberattack prompts Medicare loan program

explore

hotspot

hotspot

leisure time